Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Zeneca describes nonpeptide antagonists of NK2 receptors

Jan. 8, 1997

Improved formulation of Vanceril approved for market

Jan. 7, 1997

Genome Therapeutics and Schering-Plough genomic-based collaboration

Dec. 31, 1996

Heterocyclic tachykinin antagonists revealed by Zeneca

Dec. 31, 1996

New NK1 antagonists from Ciba-Geigy

Dec. 31, 1996

Dual-action compounds with antiasthma activity reported by Kowa

Dec. 30, 1996

Novel antihistamine formulation approved by FDA

Dec. 24, 1996

LIDAK develops drug discovery approach for asthma

Dec. 23, 1996

Boehringer Ingelheim's modified anti-ICAM-1 antibodies for inflammatory disorders

Dec. 23, 1996

Cortech regains rights to elastase inhibitor

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
SERCA inhibitor shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, researchers...